Cargando…
TCF12 Activates TGFB2 Expression to Promote the Malignant Progression of Melanoma
SIMPLE SUMMARY: Melanoma is the deadliest form of skin cancer, with the BRAF(V600E) mutation being the most prevalent driver mutation. Despite targeted therapies against BRAF(V600E) mutation and immune checkpoint-blocking antibodies providing treatment options for patients, the heterogeneous nature...
Autores principales: | Tian, Youjia, Zhou, Jiang, Chai, Xinxin, Ping, Zejun, Zhao, Yurong, Xu, Xin, Luo, Chi, Sheng, Jinghao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527220/ https://www.ncbi.nlm.nih.gov/pubmed/37760480 http://dx.doi.org/10.3390/cancers15184505 |
Ejemplares similares
-
Comprehensive characterization of TGFB1 across hematological malignancies
por: Wang, Cui-zhu, et al.
Publicado: (2023) -
HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer
por: He, Junyi, et al.
Publicado: (2016) -
TCF12 activates MAGT1 expression to regulate the malignant progression of pancreatic carcinoma cells
por: Wang, Ling, et al.
Publicado: (2022) -
Multidimensional analysis of gene expression reveals TGFB1I1-induced EMT contributes to malignant progression of astrocytomas
por: Liu, Yanwei, et al.
Publicado: (2014) -
TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets TGFB2 and SOX2
por: Zhou, Cixiang, et al.
Publicado: (2022)